| Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function JJ Sabatino Jr, K Mittl, WM Rowles, K McPolin, JV Rajan, MT Laurie, ... JCI insight 7 (4), 2022 | 75 | 2022 |
| Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions KM Krysko, SC LaHue, A Anderson, A Rutatangwa, W Rowles, ... Neurology: Neuroimmunology & Neuroinflammation 7 (1), e637, 2019 | 58 | 2019 |
| Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis F Novak, AC Nilsson, C Nielsen, DK Holm, K Østergaard, A Bystrup, ... Multiple sclerosis and related disorders 56, 103251, 2021 | 40 | 2021 |
| A videogame-based digital therapeutic to improve processing speed in people with multiple sclerosis: a feasibility study RM Bove, G Rush, C Zhao, W Rowles, P Garcha, J Morrissey, A Schembri, ... Neurology and therapy 8, 135-145, 2019 | 40 | 2019 |
| Clinical and radiologic disease activity in pregnancy and postpartum in MS A Anderson, KM Krysko, A Rutatangwa, T Krishnakumar, C Chen, ... Neurology: Neuroimmunology & Neuroinflammation 8 (2), e959, 2021 | 30 | 2021 |
| A precision medicine tool for patients with multiple sclerosis (the open MS BioScreen): human-centered design and development E Schleimer, J Pearce, A Barnecut, W Rowles, A Lizee, A Klein, VJ Block, ... Journal of medical Internet research 22 (7), e15605, 2020 | 29 | 2020 |
| A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: a pilot study R Bove, W Rowles, C Zhao, A Anderson, S Friedman, D Langdon, ... Multiple Sclerosis Journal 27 (5), 778-789, 2021 | 26 | 2021 |
| Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients HM Bajwa, F Novak, AC Nilsson, C Nielsen, DK Holm, K Østergaard, ... Multiple sclerosis and related disorders 60, 103729, 2022 | 24 | 2022 |
| Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity JJ Sabatino Jr, K Mittl, W Rowles, K Mcpolin, JV Rajan, CR Zamecnik, ... medRxiv, 2021 | 24 | 2021 |
| Expanded access to multiple sclerosis teleneurology care following the COVID-19 pandemic MP McGinley, S Gales, W Rowles, Z Wang, WY Hsu, L Amezcua, R Bove Multiple Sclerosis Journal–Experimental, Translational and Clinical 7 (1 …, 2021 | 23 | 2021 |
| Unmet needs in the evaluation, treatment, and recovery for 167 children affected by acute flaccid myelitis reported by parents through social media R Bove, W Rowles, M Carleton, E Olivera, M Sheehan, HP Werdal, ... Pediatric Neurology 102, 20-27, 2020 | 22 | 2020 |
| Transitioning From S1P Receptor Modulators to B Cell–Depleting Therapies in Multiple Sclerosis: Clinical, Radiographic, and Laboratory Data WM Rowles, WY Hsu, K McPolin, A Li, S Merrill, CY Guo, AJ Green, ... Neurology: Neuroimmunology & Neuroinflammation 9 (4), e1183, 2022 | 15 | 2022 |
| Effects of melatonin on sleep disturbances in multiple sclerosis: A randomized, controlled pilot study WY Hsu, A Anderson, W Rowles, KE Peters, V Li, KL Stone, LH Ashbrook, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 7 (4 …, 2021 | 14 | 2021 |
| Application of an adaptive, digital, game-based approach for cognitive assessment in multiple sclerosis: observational study WY Hsu, W Rowles, JA Anguera, C Zhao, A Anderson, A Alexander, ... Journal of Medical Internet Research 23 (1), e24356, 2021 | 14 | 2021 |
| Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators JJ Sabatino Jr, K Mittl, W Rowles, CR Zamecnik, RP Loudermilk, ... Multiple Sclerosis and Related Disorders 70, 104484, 2023 | 13 | 2023 |
| An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis AR Romeo, WM Rowles, ES Schleimer, P Barba, WY Hsu, R Gomez, ... Multiple Sclerosis Journal 27 (9), 1432-1441, 2021 | 11 | 2021 |
| A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial R Bove, A Anderson, W Rowles, KA Rankin, NK Hills, M Carleton, ... Multiple sclerosis and related disorders 61, 103747, 2022 | 9 | 2022 |
| Risk factors for peripartum depression in women with multiple sclerosis KM Krysko, A Anderson, J Singh, K McPolin, A Rutatangwa, W Rowles, ... Multiple Sclerosis Journal 28 (6), 970-979, 2022 | 9 | 2022 |
| Assessing cognitive function in multiple sclerosis with digital tools: observational study WY Hsu, W Rowles, JA Anguera, A Anderson, JW Younger, S Friedman, ... Journal of Medical Internet Research 23 (12), e25748, 2021 | 9 | 2021 |
| Anti‐CD20 monoclonal antibody therapy in postpartum women with neurological conditions A Anderson, W Rowles, S Poole, A Balan, C Bevan, R Brandstadter, ... Annals of Clinical and Translational Neurology 10 (11), 2053-2064, 2023 | 5 | 2023 |
